APHAIA PHARMA AG is a company headquartered in Germany.
Develops heart tissue grown from stem cells intended to be used as a cardiac patch for regenerative treatment of heart disease. The company focuses on stem-cell-derived tissue constructs for applications in cardiology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.